Edition:
India

China Biologic Products Holdings Inc (CBPO.OQ)

CBPO.OQ on NASDAQ Stock Exchange Global Select Market

71.00USD
19 Oct 2018
Change (% chg)

-- (--)
Prev Close
$71.00
Open
--
Day's High
--
Day's Low
--
Volume
--
Avg. Vol
127,749
52-wk High
$107.32
52-wk Low
$70.88

Select another date:

Fri, Aug 24 2018

China Biologic rejects $3.9 billion bid from former CEO

China Biologic Products Holdings Inc rejected a $3.9 billion offer from a consortium led by its former chief executive on Friday and said an affiliate of CITIC Capital had also withdrawn a competing bid.

UPDATE 3-China Biologic rejects $3.9 bln bid from former CEO

* Shares fall 14 pct (Adds former CEO-led consortium's comments)

China Biologic rejects former CEO-led consortium's offer

Aug 24 China Biologic Products Holdings Inc said on Friday it had rejected an offer from a consortium led by its former chief executive and the company said an affiliate of CITIC Capital unit had withdrawn a competing offer.

China Biologic gets $3.9 billion offer from former CEO-led consortium

China Biologic Products Holdings Inc on Monday received a $3.9 billion all-cash offer from a consortium of investment firms, valuing the Beijing-based company at slightly above an earlier buyout proposal from a CITIC Capital unit.

UPDATE 2-China Biologic gets $3.9 bln offer from former CEO-led consortium

* A Citic Capital unit offered $110 apiece for the company in June

China Biologic gets $3.9 billion offer from former CEO-led consortium

China Biologic Products Holdings Inc on Monday received a $3.9 billion all-cash offer from a consortium of investment firms led by the company's former chief executive David Gao.

CORRECTED-UPDATE 1-China Biologic gets $3.9 bln offer from former CEO-led consortium

Aug 20 China Biologic Products Holdings Inc on Monday received a $3.9 billion all-cash offer from a consortium of investment firms led by the company's former chief executive David Gao.

CORRECTED-China Biologic gets $3.9 bln offer from former CEO-led consortium

Aug 20 China Biologic Products Holdings Inc on Monday received a $3.9 billion all-cash offer from a consortium that included company's former chief executive, GL Capital Group, Bank of China Group Investment Limited and CDH Investments.

Select another date: